Eli Lilly’s obesity drug shows up to 30% weight loss in trialEli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This onc...
21 May, 2026, 10.28 PM IST
PCOS renamed: Experts propose new name for Polycystic Ovary Syndrome for better care and awareness—here's what you need to knowGlobal health experts are proposing to rename Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This cha...
12 May, 2026, 09.33 PM IST
Forget 10,000 steps: Scientists say this specific daily number is all you actually need to stop weight from coming backWeight loss: A new study is challenging the popular “10,000 steps a day” rule, suggesting you may not need that much to protect your progre...
12 May, 2026, 07.46 PM IST
Woman reveals what happened to her body after 4 weeks on Mounjaro: 'My brain is in full-blown panic because I have lost…’A content creator named Kaajal recently shared on Instagram that she lost 5 kg in just four weeks after starting Mounjaro, calling the rapi...
11 May, 2026, 07.43 PM IST
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
10 May, 2026, 08.50 AM IST
US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
05 May, 2026, 09.04 PM IST
Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
22 Apr, 2026, 03.31 PM IST
Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
13 Apr, 2026, 07.23 AM IST
Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
09 Apr, 2026, 02.52 PM IST
Eli Lilly (LLY) stock soars after FDA approves Foundayo - can this weight-loss pill drive massive growth as investors bet big on obesity drug boomEli Lilly (LLY) stock today: Eli Lilly's stock surged over 5% following the US FDA's approval of its new oral weight-loss drug, Foundayo. T...
01 Apr, 2026, 11.51 PM IST
Novo Nordisk cuts Ozempic and Wegovy prices by up to 48% as GLP-1 competition intensifies in IndiaNovo Nordisk has significantly slashed prices for Ozempic and Wegovy in India, reducing them by 36% and 48% respectively, to enhance patien...
31 Mar, 2026, 10.47 PM IST
Semaglutide patent expiry: India’s next big public health inflection pointThe expiry of a key patent for semaglutide in India opens doors for affordable weight-loss and diabetes drugs. Indian pharmaceutical compan...
19 Mar, 2026, 11.53 PM IST
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors saySemaglutide, the active ingredient in Novo's Wegovy and Ozempic, and tirzepatide, sold as Zepbound and Mounjaro by Lilly, are so effective ...
02 Oct, 2025, 03.15 PM IST
Are you really obese? Experts challenge BMI as only measure of obesity, propose new guidelines for better healthA new report from global experts calls for redefining obesity beyond the traditional body mass index (BMI) measurement. The experts propose...
15 Jan, 2025, 11.50 PM IST
This anti-diabetic drug used for weight loss has been approved by US FDA: When will India see its launch?The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in obese adults....
25 Dec, 2024, 05.59 PM IST
'Obesity paradox' decoded: Being overweight increases risk of diabetes but helps improve survival in cancer patientsWHO estimates at least 2.8 million people die each year as a result of being overweight or obese.
28 Dec, 2019, 06.29 PM IST
US approves new drug for binge eating disorderUS has approved a first of its kind prescription drug to treat moderate to severe binge eating disorder (BED) in adults.
03 Feb, 2015, 04.52 PM IST